New classes of carbazoles as potential multi-functional anti-Alzheimer's agents

被引:22
|
作者
Choubdar, Niloufar [1 ]
Golshani, Mostafa [2 ]
Jalili-Baleh, Leili [2 ]
Nadri, Hamid [3 ,4 ]
Kucukkilinc, Tuba Tuylu [5 ]
Ayazgok, Beyza [5 ]
Moradi, Alireza [3 ,4 ]
Moghadam, Farshad Homayouni [6 ]
Abdolahi, Zahra [3 ,4 ]
Ameri, Alieh [7 ]
Salehian, Fatemeh [2 ]
Foroumadi, Alireza [2 ]
Khoobi, Mehdi [2 ]
机构
[1] Islamic Azad Univ, Fac Pharmaceut Chem, Dept Organ Chem, Tehran Med Sci, Tehran, Iran
[2] Univ Tehran Med Sci, Inst Pharmaceut Sci, POB 14155-6451, Tehran 1417614411, Iran
[3] Shahid Sadoughi Univ Med Sci, Fac Pharm, Dept Med Chem, Yazd, Iran
[4] Shahid Sadoughi Univ Med Sci, Pharmaceut Sci Res Ctr, Yazd, Iran
[5] Hacettepe Univ, Fac Pharm, Dept Biochem, Ankara, Turkey
[6] ACECR, Royan Inst Biotechnol, Dept Cellular Biotechnol, Cell Sci Res Ctr, Esfahan, Iran
[7] Kerman Univ Med Sci, Fac Pharm, Dept Med Chem, Kerman, Iran
关键词
Alzheimer's disease; Acetylcholinesterase; Butyrylcholinesterase; Carbazoles; Docking study; beta-amyloid aggregation; TARGET-DIRECTED LIGANDS; ACETYLCHOLINESTERASE INHIBITORS; CHOLINESTERASE-INHIBITORS; TORPEDO-CALIFORNICA; PERIPHERAL SITE; DISEASE; DESIGN; DERIVATIVES; BINDING; AGGREGATION;
D O I
10.1016/j.bioorg.2019.103164
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Multi-Target approach is particularly promising way to drug discovery against Alzheimer's disease. In the present study, we synthesized a series of compounds comprising the carbazole backbone linked to the benzyl piperazine, benzyl piperidine, pyridine, quinoline, or isoquinoline moiety through an aliphatic linker and evaluated as cholinesterase inhibitors. The synthesized compounds showed IC50 values of 0.11-36.5 mu M and 0.02-98.6 mu M against acetyl-and butyrylcholinesterase (AChE and BuChE), respectively. The ligand-protein docking simulations and kinetic studies revealed that compound 3s could bind effectively to the peripheral anionic binding site (PAS) and anionic site of the enzyme with mixed-type inhibition. Compound 3s was the most potent compound against AChE and BuChE and showed acceptable inhibition potency for self- and AChE-induced A beta(1-42) aggregation. Moreover, compound 3s could significantly protect PC12 cells against H2O2-induced toxicity. The results suggested that the compounds 3s could be considered as a promising multi-functional agent for further drug discovery development against Alzheimer's disease.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Synthesis and biological evaluation of 3-arylcoumarins as potential anti-Alzheimer's disease agents
    Yang, Jie
    Zhang, Pingping
    Hu, Yuheng
    Liu, Teng
    Sun, Jie
    Wang, Xiaojing
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2019, 34 (01) : 651 - 656
  • [42] Synthesis and biological evaluation of 4-arylcoumarins as potential anti-Alzheimer's disease agents
    Yun, Yinling
    Yang, Jie
    Miao, Yuhang
    Wang, Xiaojing
    Sun, Jie
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (04)
  • [43] Synthesis, biological and computational evaluation of benzoxazole hybrid analogs as potential anti-Alzheimer's agents
    Othman, Mohamed S.
    Hussain, Rafaqat
    Rahim, Fazal
    Ullah, Hayat
    Khan, Shoaib
    Taha, Muhammad
    Fareid, Mohamed A.
    Altaleb, Anas T.
    Aboelnaga, Shimaa M.
    Shah, Syed Adnan Ali
    FUTURE MEDICINAL CHEMISTRY, 2024, 16 (19) : 2013 - 2023
  • [44] Beta and gamma carboline derivatives as potential anti-Alzheimer agents: A comparison
    Otto, Robert
    Penzis, Robert
    Gaube, Friedemann
    Winckler, Thomas
    Appenroth, Dorothea
    Fleck, Christian
    Traenkle, Christian
    Lehmann, Jochen
    Enzensperger, Christoph
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 87 : 63 - 70
  • [45] Bis-8-hydroxyquinoline ligands as potential anti-Alzheimer agents
    Deraeve, Celine
    Pitie, Marguerite
    Mazarguil, Honore
    Meunier, Bernard
    NEW JOURNAL OF CHEMISTRY, 2007, 31 (02) : 193 - 195
  • [46] Synthesis and screening of triazolopyrimidine scaffold as multi-functional agents for Alzheimer's disease therapies
    Kumar, Jitendra
    Meena, Poonam
    Singh, Anju
    Jameel, Ehtesham
    Maqbool, Mudasir
    Mobashir, Mohammad
    Shandilya, Ashutosh
    Tiwari, Manisha
    Hoda, Nasimul
    Jayaram, B.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 119 : 260 - 277
  • [47] Novel 3-phenylcoumarin-lipoic acid conjugates as multi-functional agents for potential treatment of Alzheimer's disease
    Jalili-Baleh, Leili
    Nadri, Hamid
    Forootanfar, Hamid
    Samzadeh-Kermani, Alireza
    Kucukkilinc, Tuba Tuylu
    Ayazgok, Beyza
    Rahimifard, Mahban
    Baeeri, Maryam
    Doostmohammadi, Mohsen
    Firoozpour, Loghman
    Bukhari, Syed Nasir Abbas
    Abdollahi, Mohammad
    Ganjali, Mohammad Reza
    Emami, Saeed
    Khoobi, Mehdi
    Foroumadi, Alireza
    BIOORGANIC CHEMISTRY, 2018, 79 : 223 - 234
  • [48] Charge Density Studies on Anti-Alzheimer Agents
    Luger, P.
    Mebs, S.
    Weber, M.
    Dittrich, B.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2014, 70 : C969 - C969
  • [49] New Tacrines as Anti-Alzheimer's Disease Agents. The (Benzo)Chromeno-PyranoTacrines
    Jesus Oset-Gasque, Maria
    Marco-Contelles, Jose
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (31) : 3349 - 3360
  • [50] New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer's and antiproliferative agents
    Roldan-Pena, Jesus M.
    Alejandre-Ramos, Daniel
    Lopez, Oscar
    Maya, Ines
    Lagunes, Irene
    Padron, Jose M.
    Pena-Altamira, Luis Emiliano
    Bartolini, Manuela
    Monti, Barbara
    Bolognesi, Maria L.
    Fernandez-Bolanos, Jose G.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 138 : 761 - 773